Biopreservation

Biopreservation

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Biopreservation Market to Reach $7.9 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Biopreservation estimated at US$4.4 Billion in the year 2022, is projected to reach a revised size of US$7.9 Billion by 2030, growing at aCAGR of 7.5% over the period 2022-2030. Biopreservation Media, one of the segments analyzed in the report, is projected to record 8.5% CAGR and reach US$5.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Biopreservation Equipment segment is readjusted to a revised 6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 12.6% CAGR
The Biopreservation market in the U.S. is estimated at US$1.2 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$2 Billion by the year 2030 trailing a CAGR of 12.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 6.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Select Competitors (Total 27 Featured) -
  • Atlanta Biologicals, Inc.
  • BioCision, LLC
  • BioGenix, LLC
  • BioLife Solutions, Inc.
  • Biomatrica, Inc.
  • LabVantage Solutions, Inc.
  • Panasonic Corporation
  • Qiagen, Inc.
  • Thermo Fisher Scientific, Inc.
  • VWR International LLC
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Biopreservation – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Biopreservation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 2: World 8-Year Perspective for Biopreservation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2023 & 2030
TABLE 3: World Recent Past, Current & Future Analysis for Biopreservation Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 4: World 8-Year Perspective for Biopreservation Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Biopreservation Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 6: World 8-Year Perspective for Biopreservation Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Human Tissue Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 8: World 8-Year Perspective for Human Tissue Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
TABLE 9: World Recent Past, Current & Future Analysis for Organs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 10: World 8-Year Perspective for Organs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 12: World 8-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Other Biospecimens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 14: World 8-Year Perspective for Other Biospecimens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
TABLE 15: World Recent Past, Current & Future Analysis for Therapeutic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 16: World 8-Year Perspective for Therapeutic Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Research Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 18: World 8-Year Perspective for Research Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Clinical Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 20: World 8-Year Perspective for Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
TABLE 21: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 22: World 8-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Biobanks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 24: World 8-Year Perspective for Biobanks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for Gene Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 26: World 8-Year Perspective for Gene Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
TABLE 27: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 28: World 8-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 30: World 8-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
TABLE 31: World Biopreservation Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
TABLE 32: USA Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 33: USA 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 34: USA Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 35: USA 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 36: USA Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 37: USA 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 38: USA Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 39: USA 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
CANADA
TABLE 40: Canada Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 41: Canada 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 42: Canada Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 43: Canada 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 44: Canada Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 45: Canada 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 46: Canada Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 47: Canada 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
JAPAN
Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
TABLE 48: Japan Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 49: Japan 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 50: Japan Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 51: Japan 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 52: Japan Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 53: Japan 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 54: Japan Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 55: Japan 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
CHINA
Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
TABLE 56: China Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 57: China 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 58: China Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 59: China 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 60: China Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 61: China 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 62: China Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 63: China 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
EUROPE
Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
TABLE 64: Europe Recent Past, Current & Future Analysis for Biopreservation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 65: Europe 8-Year Perspective for Biopreservation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2023 & 2030
TABLE 66: Europe Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 67: Europe 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 68: Europe Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 69: Europe 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 70: Europe Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 71: Europe 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 72: Europe Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 73: Europe 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
FRANCE
Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
TABLE 74: France Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 75: France 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 76: France Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 77: France 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 78: France Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 79: France 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 80: France Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 81: France 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
GERMANY
Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
TABLE 82: Germany Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 83: Germany 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 84: Germany Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 85: Germany 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 86: Germany Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 87: Germany 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 88: Germany Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 89: Germany 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
ITALY
TABLE 90: Italy Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 91: Italy 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 92: Italy Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 93: Italy 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 94: Italy Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 95: Italy 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 96: Italy Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 97: Italy 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
UNITED KINGDOM
Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
TABLE 98: UK Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 99: UK 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 100: UK Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 101: UK 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 102: UK Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 103: UK 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 104: UK Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 105: UK 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
SPAIN
TABLE 106: Spain Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 107: Spain 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 108: Spain Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 109: Spain 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 110: Spain Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 111: Spain 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 112: Spain Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 113: Spain 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
RUSSIA
TABLE 114: Russia Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 115: Russia 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 116: Russia Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 117: Russia 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 118: Russia Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 119: Russia 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 120: Russia Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 121: Russia 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
REST OF EUROPE
TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 123: Rest of Europe 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 124: Rest of Europe Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 125: Rest of Europe 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 126: Rest of Europe Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 127: Rest of Europe 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 129: Rest of Europe 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
ASIA-PACIFIC
Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
TABLE 130: Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 131: Asia-Pacific 8-Year Perspective for Biopreservation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2023 & 2030
TABLE 132: Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 133: Asia-Pacific 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 135: Asia-Pacific 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 136: Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 137: Asia-Pacific 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 138: Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 139: Asia-Pacific 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
AUSTRALIA
Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
TABLE 140: Australia Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 141: Australia 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 142: Australia Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 143: Australia 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 144: Australia Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 145: Australia 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 146: Australia Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 147: Australia 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
INDIA
Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
TABLE 148: India Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 149: India 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 150: India Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 151: India 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 152: India Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 153: India 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 154: India Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 155: India 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
SOUTH KOREA
TABLE 156: South Korea Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 157: South Korea 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 158: South Korea Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 159: South Korea 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 160: South Korea Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 161: South Korea 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 162: South Korea Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 163: South Korea 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
REST OF ASIA-PACIFIC
TABLE 164: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 165: Rest of Asia-Pacific 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 166: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 167: Rest of Asia-Pacific 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 168: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 169: Rest of Asia-Pacific 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 170: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 171: Rest of Asia-Pacific 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
LATIN AMERICA
Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
TABLE 172: Latin America Recent Past, Current & Future Analysis for Biopreservation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 173: Latin America 8-Year Perspective for Biopreservation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2023 & 2030
TABLE 174: Latin America Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 175: Latin America 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 176: Latin America Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 177: Latin America 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 178: Latin America Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 179: Latin America 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 180: Latin America Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 181: Latin America 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
ARGENTINA
TABLE 182: Argentina Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 183: Argentina 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 184: Argentina Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 185: Argentina 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 186: Argentina Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 187: Argentina 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 188: Argentina Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 189: Argentina 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
BRAZIL
TABLE 190: Brazil Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 191: Brazil 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 192: Brazil Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 193: Brazil 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 194: Brazil Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 195: Brazil 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 196: Brazil Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 197: Brazil 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
MEXICO
TABLE 198: Mexico Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 199: Mexico 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 200: Mexico Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 201: Mexico 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 202: Mexico Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 203: Mexico 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 204: Mexico Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 205: Mexico 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
REST OF LATIN AMERICA
TABLE 206: Rest of Latin America Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 207: Rest of Latin America 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 208: Rest of Latin America Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 209: Rest of Latin America 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 210: Rest of Latin America Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 211: Rest of Latin America 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 212: Rest of Latin America Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 213: Rest of Latin America 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
MIDDLE EAST
Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
TABLE 214: Middle East Recent Past, Current & Future Analysis for Biopreservation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 215: Middle East 8-Year Perspective for Biopreservation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2023 & 2030
TABLE 216: Middle East Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 217: Middle East 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 218: Middle East Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 219: Middle East 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 220: Middle East Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 221: Middle East 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 222: Middle East Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 223: Middle East 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
IRAN
TABLE 224: Iran Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 225: Iran 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 226: Iran Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 227: Iran 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 228: Iran Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 229: Iran 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 230: Iran Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 231: Iran 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
ISRAEL
TABLE 232: Israel Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 233: Israel 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 234: Israel Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 235: Israel 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 236: Israel Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 237: Israel 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 238: Israel Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 239: Israel 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
SAUDI ARABIA
TABLE 240: Saudi Arabia Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 241: Saudi Arabia 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 242: Saudi Arabia Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 243: Saudi Arabia 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 244: Saudi Arabia Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 245: Saudi Arabia 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 246: Saudi Arabia Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 247: Saudi Arabia 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
UNITED ARAB EMIRATES
TABLE 248: UAE Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 249: UAE 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 250: UAE Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 251: UAE 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 252: UAE Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 253: UAE 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 254: UAE Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 255: UAE 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
REST OF MIDDLE EAST
TABLE 256: Rest of Middle East Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 257: Rest of Middle East 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 258: Rest of Middle East Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 259: Rest of Middle East 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 260: Rest of Middle East Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 261: Rest of Middle East 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 262: Rest of Middle East Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 263: Rest of Middle East 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
AFRICA
Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
TABLE 264: Africa Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 265: Africa 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
TABLE 266: Africa Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 267: Africa 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
TABLE 268: Africa Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 269: Africa 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
TABLE 270: Africa Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 271: Africa 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings